EP4 is widely distributed, has a high affinity for PGE2, activates MAPK and PI3K, drives tumor stem cell features, and induces angiogenesis, lymphangiogenesis, and metastasis in breast cancer and melanoma (26–28). This evidence concerns the gene PTGER4 and breast cancer.